Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to -$18000.0.

  • Lisata Therapeutics' Other Non Operating Income rose 6000.0% to -$18000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$141000.0, marking a year-over-year increase of 4513.62%. This contributed to the annual value of -$257000.0 for FY2024, which is 3817.2% down from last year.
  • Per Lisata Therapeutics' latest filing, its Other Non Operating Income stood at -$18000.0 for Q3 2025, which was up 6000.0% from -$7000.0 recorded in Q2 2025.
  • In the past 5 years, Lisata Therapeutics' Other Non Operating Income ranged from a high of -$7000.0 in Q2 2025 and a low of -$187000.0 during Q1 2024
  • Its 3-year average for Other Non Operating Income is -$52000.0, with a median of -$14000.0 in 2024.
  • Data for Lisata Therapeutics' Other Non Operating Income shows a peak YoY increase of 9066.67% (in 2024) and a maximum YoY decrease of 133846.15% (in 2024) over the last 5 years.
  • Quarter analysis of 3 years shows Lisata Therapeutics' Other Non Operating Income stood at -$11000.0 in 2023, then changed by 0.0% to -$11000.0 in 2024, then plummeted by 63.64% to -$18000.0 in 2025.
  • Its Other Non Operating Income stands at -$18000.0 for Q3 2025, versus -$7000.0 for Q2 2025 and -$105000.0 for Q1 2025.